Connect with us

Hi, what are you looking for?

Jewish Business News


Japanese Daily “Nikkei”: Israeli TowerJazz In Talks To Buy Panasonic Fabs

“Nikkei”: Panasonic has started talks to sell some overseas plants to Tower, with a deal likely to be reached before early next year.


TowerJazz Japan

Panasonic Corporation (TSE: 6752) is in trouble, and Tower Semiconductor Ltd. (Nasdaq: TSEM; TASE: TSEM) may be a beneficiary. Japanese daily “Nikkei” reports that Panasonic has started talks to sell some overseas plants to Israeli circuit-maker TowerJazz with a deal likely to be reached before early next year. According to “Nikkei”, Panasonic plans to cut 7, 000 jobs from its semiconductor business, half its workforce, by March 2015, in order to deal with the company’s $15 billion in losses in the past two years.In view of Panasonic’s financial shape, if and when a deal is reached in the talks, the price that Tower will pay for the fabs is unlikely to be high. If a sale materializes, it would expand Tower’s foothold in Japan. Two years ago, it acquired the Japanese fab of Micron Technology Inc. (NYSE: MU) in Nishiwaki City. Tower needs additional production capacity to meet rising demand from its customers and to prepare for potential business in Japan.

The purpose of the acquisition is to enable Tower to meet its business target of $1 billion annual sales by 2014. The Nishiwaki fab is currently operating at one quarter capacity, after Micron reduced its procurement of chips from it.

In addition, two years ago, Tower bought a second fab in Japan, reportedly for tens of millions of dollars.

Tower declined to comment on the report.

Published by

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...


Now Platika joins and elite club of $10 billion plus Israeli firms.